Success in meeting the challenge to produce the commercial products anticipated by the exploitation of biological processes depends upon provid ing effective separation protocols. Effectiveness can be measured in terms of selectivity, purity, resolution and validatory success. The major processing problems are associated with either the selective recovery of molecules which are present in low concentrations from complex mixtures or the selective removal of contaminants from the desired molecule. Central to the evolution of processes satisfying this demand are the regulatory requirements being imposed by governments on the purity of a product, especially in the health care market. Synthetic organic chemists are increasingly finding it advantageous to conduct one or more steps using either enzymic biotransformations where molecules with a single and consistent stereochemistry or chirality are required. The underlying princi ples behind the methods, techniques and processes currently being used and developed commercially rely upon the biospecific nature and properties of the desired molecule. When these factors are married to the more traditional techniques of precipitation, chromatography, liquid-liquid extraction and membrane processes, powerful tools emerge, allowing highly selective separations to be designed. The logical extension of these combinations is to apply genetic engineering techniques to influence the separations at a more fundamental and structural level by modifying the target protein at source, during its synthesis, to facilitate its separation in a given, selective manner, leading to the distinct possibility of producing 'designer' separation programmes.
"synopsis" may belong to another edition of this title.
This book primarily concentrates on the larger molecules of immediate therapeutic interest - usually protein in nature, since these are currently at the forefront of commercial development - but chapters on molecular imprinting and chiral separations explore the opportunities available for the highly selective separation of small molecules. This is a book for biotechnologists, chemical engineers and biochemists in the academic world and industry.
Each chapter is well written, and provides a sound background understanding together with useful practical details and user experience ... It is a good source of ideas and solutions that will enable many to develop their own highly selective bioseparations. - The Genetic Engineer and Biotechnologist; This is a well put-together and presented book - highly practical in nature...Four stars. - Australian Biotechnology Association
"About this title" may belong to another edition of this title.
Shipping:
US$ 5.00
Within U.S.A.
Shipping:
US$ 53.43
From Germany to U.S.A.
Seller: P.C. Schmidt, Bookseller, Kettering, OH, U.S.A.
Hard Cover. Condition: Very Good. First Edition. a very good hardcover; an ex-library copy with usual markings; internally pages bright and clean; ---------- SATISFACTION GUARANTEED --------- FAST, COURTEOUS SERVICE ------ Size: 6 x 9". Ex-Library. Seller Inventory # A51361
Quantity: 1 available
Seller: Ammareal, Morangis, France
Hardcover. Condition: Très bon. Ancien livre de bibliothèque avec équipements. Edition 1994. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Very good. Former library book. Edition 1994. Ammareal gives back up to 15% of this item's net price to charity organizations. Seller Inventory # G-042-566
Quantity: 1 available
Seller: Buchpark, Trebbin, Germany
Condition: Gut. Zustand: Gut - Gebrauchs- und Lagerspuren. Außen: verschmutzt, angestoßen. Innen: Seiten eingerissen, Seiten verschmutzt. | Seiten: 248 | Sprache: Englisch | Produktart: Bücher. Seller Inventory # 1946021/3
Quantity: 2 available
Seller: moluna, Greven, Germany
Condition: New. Seller Inventory # 5959408
Quantity: Over 20 available
Seller: AHA-BUCH GmbH, Einbeck, Germany
Buch. Condition: Neu. Druck auf Anfrage Neuware - Printed after ordering - Success in meeting the challenge to produce the commercial products anticipated by the exploitation of biological processes depends upon provid ing effective separation protocols. Effectiveness can be measured in terms of selectivity, purity, resolution and validatory success. The major processing problems are associated with either the selective recovery of molecules which are present in low concentrations from complex mixtures or the selective removal of contaminants from the desired molecule. Central to the evolution of processes satisfying this demand are the regulatory requirements being imposed by governments on the purity of a product, especially in the health care market. Synthetic organic chemists are increasingly finding it advantageous to conduct one or more steps using either enzymic biotransformations where molecules with a single and consistent stereochemistry or chirality are required. The underlying princi ples behind the methods, techniques and processes currently being used and developed commercially rely upon the biospecific nature and properties of the desired molecule. When these factors are married to the more traditional techniques of precipitation, chromatography, liquid-liquid extraction and membrane processes, powerful tools emerge, allowing highly selective separations to be designed. The logical extension of these combinations is to apply genetic engineering techniques to influence the separations at a more fundamental and structural level by modifying the target protein at source, during its synthesis, to facilitate its separation in a given, selective manner, leading to the distinct possibility of producing 'designer' separation programmes. Seller Inventory # 9780751400519
Quantity: 1 available
Seller: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germany
Buch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Success in meeting the challenge to produce the commercial products anticipated by the exploitation of biological processes depends upon provid ing effective separation protocols. Effectiveness can be measured in terms of selectivity, purity, resolution and validatory success. The major processing problems are associated with either the selective recovery of molecules which are present in low concentrations from complex mixtures or the selective removal of contaminants from the desired molecule. Central to the evolution of processes satisfying this demand are the regulatory requirements being imposed by governments on the purity of a product, especially in the health care market. Synthetic organic chemists are increasingly finding it advantageous to conduct one or more steps using either enzymic biotransformations where molecules with a single and consistent stereochemistry or chirality are required. The underlying princi ples behind the methods, techniques and processes currently being used and developed commercially rely upon the biospecific nature and properties of the desired molecule. When these factors are married to the more traditional techniques of precipitation, chromatography, liquid-liquid extraction and membrane processes, powerful tools emerge, allowing highly selective separations to be designed. The logical extension of these combinations is to apply genetic engineering techniques to influence the separations at a more fundamental and structural level by modifying the target protein at source, during its synthesis, to facilitate its separation in a given, selective manner, leading to the distinct possibility of producing 'designer' separation programmes. 248 pp. Englisch. Seller Inventory # 9780751400519
Quantity: 2 available
Seller: Books Puddle, New York, NY, U.S.A.
Condition: New. pp. 248. Seller Inventory # 26534693
Quantity: 4 available
Seller: Majestic Books, Hounslow, United Kingdom
Condition: New. Print on Demand pp. 248 52:B&W 6.14 x 9.21in or 234 x 156mm (Royal 8vo) Case Laminate on White w/Gloss Lam. Seller Inventory # 8361850
Quantity: 4 available
Seller: Biblios, Frankfurt am main, HESSE, Germany
Condition: New. PRINT ON DEMAND pp. 248. Seller Inventory # 18534703
Quantity: 4 available